Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Fat in the liver and insulin resistance.

Yki-Järvinen H.

Ann Med. 2005;37(5):347-56. Review.

PMID:
16179270
2.

The fatty liver and insulin resistance.

Yki-Järvinen H, Westerbacka J.

Curr Mol Med. 2005 May;5(3):287-95. Review.

PMID:
15892648
3.

Fatty liver: a novel component of the metabolic syndrome.

Kotronen A, Yki-Järvinen H.

Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38. Epub 2007 Aug 9. Review.

4.
5.

Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.

Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamäki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A, Yki-Järvinen H.

Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E941-9. Epub 2004 Jan 28.

6.

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

Gastroenterology. 2008 Jul;135(1):122-30. doi: 10.1053/j.gastro.2008.03.021. Epub 2008 Mar 21.

PMID:
18474251
7.

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.

Roden M.

Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):335-48. Review.

PMID:
16932311
8.
9.

Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.

Makkonen J, Westerbacka J, Kolak M, Sutinen J, Cornér A, Hamsten A, Fisher RM, Yki-Järvinen H.

Int J Obes (Lond). 2007 Oct;31(10):1617-25. Epub 2007 Apr 24.

PMID:
17452990
10.

Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss.

Hoenig M, Thomaseth K, Waldron M, Ferguson DC.

Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R227-34. Epub 2006 Aug 10. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1291.

11.

Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.

Ahn CW, Kim CS, Nam JH, Kim HJ, Nam JS, Park JS, Kang ES, Cha BS, Lim SK, Kim KR, Lee HC, Huh KB.

Clin Endocrinol (Oxf). 2006 Apr;64(4):444-9.

PMID:
16584518
12.

Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.

Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P.

Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E282-90. Epub 2006 Feb 14.

13.

Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.

Kim C, Park J, Park J, Kang E, Ahn C, Cha B, Lim S, Kim K, Lee H.

Obesity (Silver Spring). 2006 Jul;14(7):1164-71.

14.

Liver fat content measured by magnetic resonance spectroscopy at 3.0 tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects.

Ishii M, Yoshioka Y, Ishida W, Kaneko Y, Fujiwara F, Taneichi H, Miura M, Toshihiro M, Takebe N, Iwai M, Suzuki K, Satoh J.

Tohoku J Exp Med. 2005 May;206(1):23-30.

15.

Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.

Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, Afendy A, Ong JP, Goodman Z, Chandhoke V, Younossi ZM.

Obes Surg. 2006 Sep;16(9):1118-25.

PMID:
16989692
16.

Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.

Yki-Järvinen H.

Dig Dis. 2010;28(1):203-9. doi: 10.1159/000282087. Epub 2010 May 7. Review.

PMID:
20460912
17.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

18.

Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.

Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, Kasuga M.

Metabolism. 2007 Oct;56(10):1418-24.

PMID:
17884455
19.

Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women.

Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni G, Benati C, Bambara V, Negri M, Bosello O, Zamboni M.

Am J Clin Nutr. 2006 Nov;84(5):1193-9.

20.

Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.

Annuzzi G, Giacco R, Patti L, Di Marino L, De Natale C, Costabile G, Marra M, Santangelo C, Masella R, Rivellese AA.

Nutr Metab Cardiovasc Dis. 2008 Oct;18(8):531-8. doi: 10.1016/j.numecd.2007.12.003. Epub 2008 Mar 5.

PMID:
18321693

Supplemental Content

Support Center